LeghaSS.Vincristine neurotoxicity, pathophysiology, and management. Med Toxicol1986; 1: 421–7.
2.
MacDonalDR.Neurotoxicity of chemotherapeutic agents. In: PerryMC ed. The chemotherapy sourcebook. Baltimore: Williams and Wilkins, 1992: 666–79.
3.
BertrandY, CapdevilleR, BalduckN, PhilippeN.Cyclosporin-A used to reverse drug resistance increases vincristine neurotoxicity. Am J Hematol1992; 40: 158–9.
4.
WeberDM, DimopoulosMA, AlexanianR.Increased neurotoxicity with VAD-cyclosporin in multiple myeloma. Lancet1993; 341: 558–9.
5.
HildebrandJ, KenisY.Additive toxicity of vincristine and other drugs for the peripheral nervous system. Three case reports. Acta Neurol Bel1971; 71: 486–91.
6.
DesaiZR, Van der BenrHW, BridgesJM, ShanksRG.Can severe vincristine neurotoxicity be prevented?Cancer Chemother Pharmacol1982; 8: 211–4.
7.
WeidenPL, WrightSE.Vincristine neurotoxicity. N Engl J Med1972; 286: 1369–70.
8.
MillerBR.Neurotoxicity and vincristine (letter). JAMA1985:253:2045.
